Skip to main content
Diagnostics logoLink to Diagnostics
letter
. 2020 Jul 6;10(7):457. doi: 10.3390/diagnostics10070457

Missing Skeletal Muscle Metastases of Papillary Thyroid Carcinoma

Leszek Herbowski 1
PMCID: PMC7399820  PMID: 32640503

With regard to several important gaps in the work “Skeletal Muscle Metastasis in Papillary Thyroid Microcarcinoma Evaluated by F18-FDG PET/CT” [1], it seems necessary to clarify and extend some key issues in this text.

First of all, one should agree with authors of this paper that “… one must bear in mind the fact that muscle metastasis from PTC is possible …”. Indeed, based on epidemiological data, I have estimated the occurrence of papillary or follicular thyroid carcinoma metastasis to skeletal muscles at a few cases per billion people. Thus, the probability of such exceptional metastases approaches zero, but this phenomenon does happen.

Secondly, the authors cited several cases of papillary thyroid carcinoma metastases to skeletal muscles including one more case added by themselves. The total number of cases of dissemination of PTC to skeletal muscles reported by the authors equals 13, based on the analysis of medical literature from the years 2006–2016. Certainly there are more such cases because not all diagnosed cases of rare diseases are willingly published. Nevertheless, having analyzed medical literature as far back as the last hundred and ten years, I have identified in total 58 cases of papillary (PTC) and follicular (FTC) thyroid cancer metastases to skeletal muscles: 45 cases in the considered time range 2006 through 2016, and 13 cases from 1907 to 2005 (doi: 10.3892/ol.2018.8216). Still, considering only the cases of papillary thyroid cancers (PTC) during this period (2006–2016), a total of 34 skeletal muscle metastases were described in 27 patients: 12 females (44%) and 15 males (56%) [2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27]. The mean age was 54.7 years (95% CI: 47.6–61.8; range: 25–89). There were no significant age differences between women and men (t-test: p = 0.96).

Thirdly, based on the 34 cases scrutinized in my paper, the most frequent PTC metastatic muscles were the erector spinae, gluteus and sternocleidomastoid muscle (Table 1). Although the sternocleidomastoid muscle seems to be frequently prone to PTC metastasis, after excluding three jatrogenic cases of carcinoma seeding only one natural sternocleidomastoid muscle metastasis is left [24].

Table 1.

Localization of 34 skeletal muscle metastases of papillary thyroid carcinoma (PTC).

No Muscles PTC Metastases
1 Erector spinae 4
2 Gluteus muscles 4
3 Sternocleidomastoid 4
4 Pterygoid 3
5 Trapezoid 2
6 Masseter 2
7 Thigh muscles 1
8 Piriformis 1
9 Pelvic 1
10 Deltoid 1
11 Psoas/Iliopsoas 1
12 Rectus abdominis 1
13 Biceps 1
14 Vastus 1
15 Adductor longus 1
16 Biceps femoris 1
17 Paraspinal 1
18 Temporal 1
19 Subscapularis 1
20 Gastrocnemius 1
21 Latissimus dorsi 1
Total 34

Fourthly, in a period of over one hundred years, only three cases of skeletal muscle metastases from papillary thyroid microcarcinoma were reported [17,23,28]. The first case involved the pterygoid, masseter and temporal muscles [17], the second the deltoid muscle [23] and the third the psoas muscle [28]. Hitu et al. added the next case of microcarcinoma of the papillary thyroid spreading to the gluteal muscle which was diagnosed by F18-FDG PET/CT study.

The rarer the occurrence of a given medical phenomenon, the harder and more reliable work analyzing the past should be done by the authors. In the light of the facts demonstrated here, it is difficult to consider the theses presented in the paper by Hitu et al. as reliable and consistent with prior research. The accuracy of the previously described medical cases’ analysis is based not only on the review of the medical database in terms of various categories, but above all on finding an appropriate algorithm that allows us to understand the information present but not necessarily directly specified in the text. That is why it is so important to supervise the team collecting and analyzing previously published works. Hence, the uniqueness of casuistic study is not to show that it is an exceptional work, only to prove that similar previous research consists of single cases; and I can confidently put forward a thesis that the entire review process has failed in this specific situation. Therefore, to improve the quality and validity of published work, it is necessary to supervise the construction of the research at subsequent stages of its creation and reviewing.

Funding

This research received no external funding.

Conflicts of Interest

The author declares no conflict of interest.

References

  • 1.Hitu L., Cainap C., Apostu D., Gabora K., Bonci E.-A., Badan M., Mester A., Piciu A. Skeletal Muscle Metastasis in Papillary Thyroid Microcarcinoma Evaluated by F18-FDG PET/CT. Diagnostics. 2020;10:100. doi: 10.3390/diagnostics10020100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pucci A., Suppo M., Lucchesi G., Celeste A., Viberti L., Pellerito R., Papotti M. Papillary thyroid carcinoma presenting as a solitary soft tissue arm metastasis in an elderly hyperthyroid patient. Case report and review of the literature. Virchows Arch. 2006;448:857–861. doi: 10.1007/s00428-006-0187-4. [DOI] [PubMed] [Google Scholar]
  • 3.Tamiolakis D., Antoniou C., Venizelos J., Lambropoulou M., Alexiadis G., Ekonomou C., Tsiminikakis N., Alifieris E., Papadopoulos N., Konstandinidis T., et al. 2006 Papillary thyroid carcinoma metastasis most probably due to fine needle aspiration biopsy. A case report. Acta Dermatovenerol. Alp. Pannonica Adriat. 2006;15:169–172. [PubMed] [Google Scholar]
  • 4.Panoussopoulos D., Theodoropoulos G., Vlahos K., Lazaris A.C., Papadimitriou K. Distant solitary skeletal muscle metastasis from papillary thyroid carcinoma. Int. Surg. 2007;92:226–229. [PubMed] [Google Scholar]
  • 5.Kim J.H., Choi Y.J., Kim J.A., Gil W.H., Nam S.J., Oh Y.L., Yang J.H. Thyroid cancer that developed around the operative bed and subcutaneous tunnel after endoscopic thyroidectomy via a breast approach. Surg. Laparosc. Endosc. Percutan. Tech. 2008;18:197–201. doi: 10.1097/SLE.0b013e318168dda4. [DOI] [PubMed] [Google Scholar]
  • 6.Luo Q., Luo Q.Y., Sheng S.W., Chen L.B., Yu Y.L., Lu H.K., Zhu R.S. Localization of concomitant metastases to kidney and erector spinae from papillary thyroid carcinoma using (131)I-SPECT and CT. Thyroid. 2008;18:663–664. doi: 10.1089/thy.2007.0326. [DOI] [PubMed] [Google Scholar]
  • 7.Bruglia M., Palmonella G., Silvetti F., Rutigliano P., Criante P., Marmorale C., Boscaro M., Taccaliti A. Skin and thigh muscle metastasis from papillary thyroid cancer. Singapore Med. J. 2009;50:e61–e64. [PubMed] [Google Scholar]
  • 8.Qiu Z.L., Luo Q.Y. Erector spinae metastases from differentiated thyroid cancer identified by I-131 SPECT/CT. Clin. Nucl. Med. 2009;34:137–140. doi: 10.1097/RLU.0b013e31819675b6. [DOI] [PubMed] [Google Scholar]
  • 9.Zhao L.X., Li L., Li F.L., Zhao Z. Rectus abdominis muscle metastasis from papillary thyroid cancer identified by I-131 SPECT/CT. Clin. Nucl. Med. 2010;35:360–361. doi: 10.1097/RLU.0b013e3181d6265b. [DOI] [PubMed] [Google Scholar]
  • 10.Krajewska J., Olczyk T., Roskosz J., Paliczk-Cieślik E., Smietana A.K., Kaczmarek-Borowska B., Jarząb B. Treatment with sorafenib in advanced thyroid cancer - a case report. Endokrynol. Pol. 2010;61:492–496. [PubMed] [Google Scholar]
  • 11.Droz J.P. Pitfalls and uncommon problems in thyroid cancer management. Cancer World. 2010;37:15–22. [Google Scholar]
  • 12.Pascual R.C., Castaneda J.F., Romualdez J.A. Papillary thyroid carcinoma presenting with a right preauricular and intracranial mass. Philipp. J. Otolaryngol. Head Neck Surg. 2010;25:26–30. doi: 10.32412/pjohns.v25i1.657. [DOI] [Google Scholar]
  • 13.Bae S.Y., Lee S.K., Koo M.Y., Hur S.M., Choi M.Y., Cho D.H., Choe J.H., Kim J.H., Kim J.S. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma. Thyroid. 2011;21:1027–1031. doi: 10.1089/thy.2010.0249. [DOI] [PubMed] [Google Scholar]
  • 14.Caobelli F., Paghera B., Panarotto M.B., Camoni L., Giubbini R. Two distant muscular metastases from papillary carcinoma of the thyroid demonstrated by (18)F-FDG PET/CT and confirmed by biopsy. Nucl. Med. Mol. Imaging. 2011;45:324–325. doi: 10.1007/s13139-011-0112-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Li S., Zhang F., Zhang Y., Liang Y., Qi X., Yang X., Jiang J. Implantation at sternocleidomastoid and chest wall after endoscopic thyroid carcinoma surgery. Surg. Laparosc. Endosc. Percutan. Tech. 2012;22:e239–e242. doi: 10.1097/SLE.0b013e318259f43b. [DOI] [PubMed] [Google Scholar]
  • 16.Mohapatra T., Arora A., Bethune N.N. Coexisting iodine avid and iodine nonconcentrating lesions with multiple distant soft tissue metastasis in papillary thyroid cancer. Indian J. Nucl. Med. 2012;27:38–41. doi: 10.4103/0972-3919.108853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Morita N., Morimoto K., Yonezawa K., Otsuki N., Nibu K. Infratemporal fossa metastasis of papillary thyroid cancer. Head Neck. 2013;35:E119–E121. doi: 10.1002/hed.21951. [DOI] [PubMed] [Google Scholar]
  • 18.Califano I., Quildrian S., Coduti M., Rojas Bilbao E., Otero J., Califano L. Soft tissue metastases from differentiated thyroid cancer diagnosed by 1⁸F FDG PET-CT. Arq Bras. Endocrinol. Metabol. 2013;57:317–321. doi: 10.1590/S0004-27302013000400007. [DOI] [PubMed] [Google Scholar]
  • 19.Ceriani L., Treglia G., Paone G., Bongiovanni M., Franscella S., Giovanella L. Unusual muscular metastases from papillary thyroid carcinoma detected by fluorine-18-fluorodeoxyglucose PET/MRI. J. Clin. Endocrinol. Metab. 2013;98:2208–2209. doi: 10.1210/jc.2013-1472. [DOI] [PubMed] [Google Scholar]
  • 20.Madan R., Goyal S., Dinda A.K., Maohanti B.K. Papillary carcinoma of thyroid with paranasal sinus metastases. Clin. Cancer Investig. J. 2013;2:90–92. doi: 10.4103/2278-0513.110817. [DOI] [Google Scholar]
  • 21.Yun K.J., Kim W., Kim E.H., Kim M.H., Lim D.J., Kang M.I., Cha B.Y. 2014 Accelerated disease progression after discontinuation of sorafenib in a patient with metastatic papillary thyroid cancer. Endocrinol. Metab. (Seoul) 2014;29:388–393. doi: 10.3803/EnM.2014.29.3.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yang J., Li L.F., Zhang X.M., Xu Q., Zhang J., Weng W.W., Dong M.J. Unusual synchronous skeletal muscle and lung metastasis in papillary thyroid cancer: A case report and review of the literature. Oncol. Lett. 2015;9:727–730. doi: 10.3892/ol.2014.2742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Sarma M., Sonik B., Subramanyam P., Sundaram P.S. Isolated skeletal muscle metastatic deposit in a patient with micropapillary carcinoma thyroid identified by 18F FDG PET CT. J. Egypt Natl. Canc. Inst. 2015;27:47–50. doi: 10.1016/j.jnci.2015.01.002. [DOI] [PubMed] [Google Scholar]
  • 24.Portela R.A., Choby G.W., Manni A., Campbell D., Crist H., Goldenberg D. Unusual sites of metastasis of papillary thyroid cancer: Case series and review of the literature. Ear Nose Throat J. 2015;94:E43–E47. [PubMed] [Google Scholar]
  • 25.Cassidy D.J., Gupta G.K., Graham R.A. Metastasis of papillary thyroid cancer to the soft tissue of the back in the setting of recurrent disease. AMSRJ. 2015;1:206–211. doi: 10.15422/amsrj.2015.03.017. [DOI] [Google Scholar]
  • 26.Li Z.G., Lin Z.C., Mu H.Y. Polysplenia syndrome with splenic and skeletal muscle metastases from thyroid carcinoma evaluated by FDG PET/CT: Case report and literature review: A care-compliant article. Medicine (Baltimore) 2016;95:e2532. doi: 10.1097/MD.0000000000002532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kuscic L.J., Klancnik M., Paladin I., Kuna S.K. Obstructive nephropathy caused by renal metastasis of papillary thyroid carcinoma: A case report. Endocr. Oncol. Metab. 2016;2:94–98. doi: 10.21040/eom/2016.2.11. [DOI] [Google Scholar]
  • 28.Baloch Z.W., LiVolsi V.A. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod. Pathol. 2000;13:861–865. doi: 10.1038/modpathol.3880153. [DOI] [PubMed] [Google Scholar]

Articles from Diagnostics are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES